“I am excited to join AVAVA’s Board of Directors and work with a team committed to advancing the next generation of ...

Cette étude, certes soutenue par le « National Pork Board » américain, et menée par des nutritionnistes de l'Université ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its position as a regional leader in advanced ...

Harold’s financial expertise and leadership in scaling up high-growth, healthcare companies are an invaluable addition to ...

Orion Corporation (“Orion”) and Invenra Inc. (“Invenra”), an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today announced that they have entered ...

IXIARO ® is the only JE vaccine approved by the U.S. Food and Drug Administration (FDA), having been developed through a cooperative research and development agreement with the Walter Reed Army ...

Saudi hospitals have made significant strides in the 2025 Brand Finance global ranking of the world’s Top 250 hospitals, with seven Saudi hospitals making the list, including two in the top 100 ...

Certains facteurs semblent favoriser/limiter la prescription du sémaglutide chez les adultes obèses, non diabétiques, conclut ...

La grossesse peut augmenter le risque de maladie mentale chez les femmes atteintes de sclérose en plaques (SEP), souligne cette équipe de neurologues de l’Université Dalhousie (Halifax, Canada). L’étu ...

Cette équipe de l’Université de Fribourg a suivi l’évolution physique et cognitive de près de 1.000 personnes diagnostiquées ...

European patents expand coverage for both essential components of FemBloc for fallopian tube occlusion, resulting in non-surgical permanent contraception ATLANTA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- ...

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...